Explore By Subject Area   
Return Home
Register Here Menu

PODD: Partnerships in Drug Delivery

Date: Oct 28, 2024 - Oct 29, 2024

Location: Boston, MA

Day 1 October 16, 2023: Monday, October 16, 2023
Showing Events in 1 Track from 08:00am to 09:00am
Morning General Session
8:00AM - 8:30AM
Registration, Coffee & Tea (4th Floor)
8:30AM - 8:35AM
Co-Chairs' Opening Remarks
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
8:35AM - 9:00AM
Roche’s Industry Overview on the Drug Delivery Landscape 2023
Speakers:
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
Showing Events in 1 Track from 09:00am to 09:30pm
KEYNOTE
9:00AM - 9:30PM
Annual Keynote with MIT’s Dr Robert Langer
Moderated by:
Stéphane Bancel, MBA, CEO, Moderna
Speaker:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
With:
Showing Events in 1 Track from 09:30am to 10:15pm
Morning Sessions
9:30AM - 10:00AM
AI/ML: Using Computational Biology to Design Better Drug Delivery Systems and Discover Better Targets
Moderated by:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Lovisa Afzelius, PhD, MBA, Origination Partner, Flagship Pioneering
Vikram Agarwal, PhD, Head of mRNA Platform Design Data Science, Sanofi
John Quackenbush, PhD, Henry Pickering Walcott Professor of Computational Biology & Biostatistics, Harvard TH Chan School of Public Health
Daniel Reker, PhD, Assistant Professor of Biomedical Engineering, Duke University
10:00AM - 10:15PM
Time-To-Market: An Obvious Yet Perpetual Challenge
Speakers:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
PODD Grand Opening Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Graciously hosted by:
Showing Events in 1 Track from 11:05am to 11:30am
Sustainability Keynote
11:05AM - 11:30AM
Sustainability Keynote - Laying a Path for a More Sustainable Future in the Device R&D Space
Speakers:
Marianne Ølholm, DVM, PhD, DMSc, Senior Vice President, Devices & Delivery Solutions, Novo Nordisk
Ann Daugherty, PhD, Senior Manager, Genentech
Showing Events in 1 Track from 11:30am to 12:30pm
Morning Second Session
11:30AM - 11:45AM
De-Risking Combination Product Development to Support Biocompatibility and Minimize Development Timelines
Speakers:
Yitian Xiao, Scientific Business Development Leader, BD Medical
11:45AM - 12:15PM
13th Annual Pharma Company Spotlights
Speakers:
Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
Jim MacKrell, PhD, Associate Vice President & Head of East Coast (US) Venture Science - Lilly New Ventures, Eli Lilly and Company
With:
12:15PM - 12:30PM
Lost in Translation: Interpreting Between Science, Design and Manufacturing of Platform Drug Delivery Devices
Speakers:
Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize
Showing Events in 1 Track from 12:30pm to 01:40pm
Luncheon & Partnering Meetings
12:30PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 4 Tracks from 01:55pm to 03:55pm
Track 1A: Injectable Formulations & Polymers
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
1:55PM - 2:10PM
Container Closure Integrity Phenomenology and Failure Mechanisms During Deep Cold Storage
Speakers:
Sukanya Murali, PhD, Technical Services Manager, Key Accounts, BD
2:10PM - 2:25PM
SynBiosys®: Long-Acting Injectable Microspheres & In Situ Forming Depots for Delivery of Small Molecules & Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:25PM - 2:40PM
Apisolex™ Polymer: A New Enabling Tool for Insoluble Injectables – Simple Processing, High Drug Loading, and Lifecycle Management
Speakers:
Robert Lee, President, CDMO Division, Lubrizol Life Science
2:40PM - 2:55PM
A Novel Surfactant Dramatically Increasing the Stability and Concentration of Biologic Formulations
Speakers:
Bryan Mazlish, CEO, Surf Bio
2:55PM - 3:10PM
PharmaShell – New Possibilities for Long-Acting Injectable Formulations
Speakers:
David Westberg, CEO, Nanexa
3:10PM - 3:25PM
XeriJect™: Enabling Subcutaneous Delivery of High-Concentration Monoclonal Antibodies
Speakers:
Rick Fitch, PhD, Senior Director, Nonclinical Research & Development, Xeris Pharmaceuticals
3:25PM - 3:40PM
Scale-Up Challenges and Solutions for Long-Acting Injectables
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
3:40PM - 3:47PM
Pendant Functionalized Polymers: Boldly Going Where No PLGA Has Gone Before
Speakers:
C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences
3:47PM - 3:55PM
SQore™ Enabled High Concentration mAb Formulations for Patient-Delivered Subcutaneous Delivery
Speakers:
Yuhong Zeng, PhD, Director of Formulation, Comera Life Sciences
Track 1B: Oral, Mucosal, Nasal and Other Non-Injectable Technologies
Chaired by:
Sarah Tao, PhD, Head of External Innovation, Biologics and Small Molecules Sanofi Partnering, Global Business Development and Licensing, Sanofi
1:55PM - 2:10PM
Nasal Routes Explored: Diving into Intranasal Delivery and Essential Aspects
Speakers:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:10PM - 2:25PM
Apinovex™ Polymer: A New Tool for Oral Solubility Enhancement, Improved Patient Experience and Lifecycle Management
Speakers:
Nick DiFranco, MEM, Global Market Manager, Oral Drug Delivery and Novel Excipients, Lubrizol Life Science
2:25PM - 2:40PM
Multiparticulates – A Versatile Tool For Patient-Centric Fixed Dose Combination Applications
Speakers:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Business Support & New Technologies, Adare Pharma Solutions
2:40PM - 2:55PM
Controlling Drug Release Rate and Location Through 3D Printed Dosage Forms
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
2:55PM - 3:10PM
Best Practices for Optimizing Route of Delivery for Improving Drug Development Outcomes
Speakers:
Ryan Doxey, Director, Technical Services, Kymanox
Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox
3:10PM - 3:25PM
BIONDD™ – Oral Delivery of Biologics – Effective Transitioning Injectables to a Capsule
Speakers:
Karsten Lindhardt, MSc, PhD, DBE, CEO and Founder, Biograil ApS
3:25PM - 3:40PM
SpraySol – A Solution for NCE’s with Low Bioavailability
Speakers:
Usha Pillai, PhD, PMP, PhD, PMP, Pharmacin
3:40PM - 3:47PM
Solving the Insoluble – A Eutectic Approach to Enhancing Oral Bioavailability
Speakers:
Niall Hodgins, Co-Founder & CEO, SeraNovo
3:47PM - 3:55PM
Can Spraying be Precise? Introducing SPRACISE® – a Novel Platform for Localized Deep Nasal Delivery.
Speakers:
Oren Berkowitz, PhD, Clinical Lead, Clexio
Track 1C: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research
1:55PM - 2:10PM
New Perspectives on Nanoparticle Platforms for Navigating Genetic Nanomedicine Through Regulatory Pathways
Speakers:
Anthony Duong, PhD, Principle Research Scientist, Battelle
2:10PM - 2:25PM
A Novel Prefilled Drug Delivery Platform: Expanding Access and Distribution
Speakers:
Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect
2:25PM - 2:40PM
Designing for Human Nature: What Makes a Truly Engaging Drug Delivery Solution?
Speakers:
Dan Lock, Design Insight & Strategy Lead, TTP
2:40PM - 2:55PM
Double Development, Double Speed
Speakers:
Matthew Fordham, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership
2:55PM - 3:10PM
Scalable, Translatable, Dependable – Renishaw’s Delivery Platform for Drugs & Biologics
Speakers:
Stuart Campbell, Clinical Sales & Business Development Manager, Renishaw
3:10PM - 3:25PM
Revolutionary Gas-Powered Auto-injector Platform for All Drug Viscosities and Volumes
Speakers:
Matt McCawley, CTO, Altaviz, Picocyl
3:25PM - 3:40PM
The LTS Sorrel Platform – Solving Dilemmas in the Fill/Finish Process
Speakers:
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
3:40PM - 3:47PM
Next Generation Smart Needle-Free Drug Delivery Platform Targeting Frequent Injections in Remote Healthcare Setting
Speakers:
Alina Su, PhD, Founder & CEO, NovaXS
3:47PM - 3:55PM
A Rugged, Reliable, Portable, Safe and Simple Auto-Injector
Speakers:
Conor Cullinane, PhD, President & CEO, Pirouette Medical
Track 1D: Cell & Gene Delivery
Chaired by:
Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi
1:55PM - 2:10PM
Biodegradable Lipid Nanoparticles for Gene Therapy and Vaccines with Room Temperature Stability
Speakers:
Sakura Taneichi, Research Scientist, NOF Corporation
2:10PM - 2:25PM
Advances in Nanotechnologies for Delivery of Biologics and Small Molecules
Speakers:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:25PM - 2:40PM
SORT LNP-formulated mRNA for the Treatment of Primary Ciliary Dyskinesia
Speakers:
Brandon Wustman, PhD, Senior Vice President, Research, ReCode Therapeutics
2:40PM - 2:55PM
Pioneering Programmable Medicines
Speakers:
Stuart Milstein, PhD, Chief Platform Officer, Senda Biosciences
2:55PM - 3:10PM
Establishing a Robust Process Control Strategy for NA-LNPs
Speakers:
Antonio Costa, PhD, CEO, DIANT Pharma
3:10PM - 3:25PM
Choosing the Right Microfluidic Mixing Platform: How Critical is This First Step Towards the Clinic?
Speakers:
Nicholas Boylan, PhD, Director, Nucleic Acid Delivery, Phosphorex
3:25PM - 3:40PM
Ushering in the New Era of Genetic Medicine with the Fusogenix Proteo-Lipid Vehicle Delivery Platform
3:40PM - 3:47PM
Dose-Adjustable Gene Therapy Platform Technology – Prometheus
Speakers:
Alex Goraltchouk, MBA, COO, Remedium Bio
3:52PM - 3:55PM
Immuno-LNP Delivers Diverse Therapeutic Payloads Across the BBB
Speakers:
Joe Harford, PhD, President & CEO, SynerGene Therapeutics
Showing Events in 1 Track from 03:55pm to 04:10pm
Break
3:55PM - 4:10PM
15-Minute Ice-Cream Break (3rd Floor)
Graciously Hosted by:
Showing Events in 4 Tracks from 04:15pm to 06:30pm
Track 1B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
4:15PM - 4:30PM
A Novel Method to Optimizing Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs
Speakers:
Asmita Khanolkar, Senior Director, SMC LTD
4:30PM - 4:45PM
Molly Connected Cap Shapes Pharma’s Digital Health Path with Innovation Partnerships
Speakers:
Nagisa Kobashi, Product Manager for Global Emerging Technology & Digital Health, SHL Medical
4:45PM - 5:00PM
De-Risking Combination Product Programs Through a Collaborations’ Integrated Device Approach From Primary Package to Final Assembly
Speakers:
Josh Gordon, Product Manager, Auto-Injectors, Stevanato Group
5:00PM - 5:15PM
Addressing Unsolved Autoinjector Needs is Key to Enable Administration of High-Dose Biologics
Speakers:
Gaurtam Shetty, PhD, Founder & CEO, Congruence Medical Solutions
5:15PM - 5:30PM
Syringe System Innovation Driving Evolution Of Dual-Chamber Prefilled Syringe System Design, Development & Manufacturing
Speakers:
Laxman Halleppanavar, Director - Commercial Engineering Project Management, Credence Medsystems
5:30PM - 5:45PM
Technical & Human Factors Considerations for High Viscosity/High Volume Injection
Speakers:
Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo
5:45PM - 6:00PM
Maximizing the Value Your Material Supplier Can Bring to Your Drug Delivery Device Design for Precision Friction Performance
Speakers:
Don DeMello, Principal Application Development Engineer - Medical, Celanese
6:00PM - 6:15PM
Ypsomed’s Approach to the Growing Market for Injection Device Solutions
Speakers:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
Track 2B: Injectable & Non-Injectable Formulation Technologies
Chaired by:
Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, NIBR
4:15PM - 4:30PM
Polymeric Drug Delivery Technology for Sustained Release of Small and Large Molecules
Speakers:
Keith Henry, MBA, New Business Development Leader, Celanese
4:30PM - 4:45PM
From Micro to Nano: Block Copolymers Enable Nanoparticle Drug Products for the Treatment of New Therapeutic Modalities
Speakers:
Whitney Beysselance Moro, PhD, Director, Strategic & Technical Marketing, Evonik
4:45PM - 5:00PM
The Viscosity Reduction Platform: An Excipient Portfolio Enabling Reduction of Viscosity While Maintaining Protein Stability
Speakers:
Lydon Salins, PhD, Technical Application Manager, Biomolecule/Liquid Formulation, Millipore Sigma
5:00PM - 5:15PM
Overcoming Challenges with Formulation of Nucleophilic APIs in the Development of Long-Acting Therapies
Speakers:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, DSM Biomedical
5:15PM - 5:30PM
PURASORB® Lactide-Glycolide Bioresorbable Copolymers for Creating Effective Long-Acting Injectables
Speakers:
Julien Bérard, MBA, Global Director, Business Development Biomaterials, Corbion
5:30PM - 5:45PM
BEPO Technology: Addressing Patient Needs Through Best-In-Class Long-Acting Injectables
Speakers:
Christophe Roberge, PhD, Partnering Director, Senior Expert Science & Technology, MedinCell
5:45PM - 6:00PM
Benefits of Diffusion-Based Implantable Drug Delivery Technology for Long-Term Delivery Windows (6-12 mo.) Mediated via Porous Media
Speakers:
Alex Hill, Senior Research Scientist, Mott Corporation
6:00PM - 6:07PM
Robust Delivery of Biologics with Novel DELOS Nanovesicles
Speakers:
Alba Córdoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
6:07PM - 6:15PM
Revolutionizing Antiviral Treatments – Orally Available Nanomedicines that Can Also Deliver Difficult APIs and Improve Their PK
Speakers:
Anil Diwan, PhD, President & Exectuive Chairman, Nanoviricides
Track 3B: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
4:15PM - 4:30PM
Revolutionizing Injectable Therapies: Overcoming Key Challenges in Drug Delivery with a Needle-Free and Connected Solution
Speakers:
Veena Rao, PhD, President & Chief Business Officer, Portal Instruments
4:30PM - 4:45PM
Advancements in Micro Molding for Drug Delivery – What is Now Possible
Speakers:
Brent Hahn, MBA, VP, Business Development & Strategy, Isometric Micro Molding
4:45PM - 5:00PM
How Pharma Can Avoid Creating Dysfunctional Connected Device Development Programs & Organizations
Speakers:
Jim McGough, Co-Founder & Director, EdgeOne Medical
5:00PM - 5:15PM
Halozyme’s ENHANZE Drug Delivery Technology Enables Rapid High Volume Subcutaneous Drug Delivery Expanding Autoinjector
Speakers:
Michael LaBarre, PhD, Chief Technical Officer, Halozyme
5:15PM - 5:30PM
What’s Beyond 10mL? Unique Learnings in Large Volume Subcutaneous Infusion
Speakers:
Josh Bennett, General Manager of Novel Therapies, Koru Medical
5:30PM - 5:45PM
Potential Financial Cost Implications When Developing a Connected Drug Delivery Device, Versus a Non-Connected Product
Speakers:
Chris Hurlstone, Technical Director, Team Consulting
5:45PM - 6:00PM
How to Better Deal With the Challenges of Mixing & Delivering Highly Viscous Drugs
Speakers:
Claire Authesserre, PhD, Project Manager, Eveon
6:00PM - 6:15PM
Accelerating Development of User-Driven Connected Devices & Combination Products
Speakers:
Mark Tunkel, Global Category Director, Services, Nemera
6:15PM - 6:22PM
Reimagining the Potential of Intradermal Delivery with a Novel Injection Platform
Speakers:
Nicky Bertollo, PhD, Co-Founder & CTO, Pharma Latch
6:22PM - 6:30PM
Revolutionizing Drug Delivery to Challenging Brain Regions for a Diverse Range of Therapeutics & Localized Brain Conditions
Speakers:
Paul Schultz, SVP, Business Development, Bionaut Labs
Track 4B: Cell, Gene & Other Biologics Delivery
Chaired by:
Andrew Kroetsch, PhD, Associate Director, Takeda Pharmaceuticals
4:15PM - 4:30PM
The Potential of Eliminating Cold Chain Storage for Vaccine Distribution & Delivery
Speakers:
Mike Ratigan, Commercial Head, Advanced Pulmonary Delivery, Kindeva Drug Delivery
4:30PM - 4:45PM
Redefining Non-Viral Delivery for Novel Genomic Medicines with Hopewell’s Tissue-Targeted Lipid Nanoparticle (ttLNP) Platformn
Speakers:
Kate Zhang, PhD, Chief Scientific Officer, Hopewell Therapeutics
4:45PM - 5:00PM
Modulating Neutrophil Activity in Disease Using Targeted mRNA and Small Molecule Delivery
5:00PM - 5:15PM
BactPac™: A Bacteria-based Drug Delivery Platform to Enable the Next Generation of Nucleic Acid and Gene Therapies
Speakers:
Ashley Williams, PhD, Director of Research & Development, SiVec Biotechnologies
5:15PM - 5:30PM
Sustained Release Biologic Implants for the Treatment of Retinal Disease
Speakers:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:30PM - 5:45PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speakers:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
Showing Events in 1 Track from 06:30pm to 07:35pm
Networking
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Graciously Hosted by:
7:30PM - 7:35PM
Day One Concludes
Showing Events in 1 Track from 08:00am to 09:00am
Morning General Session
8:00AM - 8:30AM
Registration, Coffee & Tea (4th Floor)
8:30AM - 8:35AM
Co-Chairs' Opening Remarks
Speakers:
Ann Daugherty, PhD, Senior Manager, Genentech
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
8:35AM - 9:00AM
Roche’s Industry Overview on the Drug Delivery Landscape 2023
Speakers:
Mark Schiebler, PhD, Global Search and Evaluation Lead for Research Technologies, F. Hoffman La Roche
Showing Events in 1 Track from 09:00am to 09:30pm
KEYNOTE
9:00AM - 9:30PM
Annual Keynote with MIT’s Dr Robert Langer
Moderated by:
Stéphane Bancel, MBA, CEO, Moderna
Speaker:
Robert Langer, PhD, David H. Koch Institute Professor, MIT
With:
Showing Events in 1 Track from 09:30am to 10:15pm
Morning Sessions
9:30AM - 10:00AM
AI/ML: Using Computational Biology to Design Better Drug Delivery Systems and Discover Better Targets
Moderated by:
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Panelists:
Lovisa Afzelius, PhD, MBA, Origination Partner, Flagship Pioneering
Vikram Agarwal, PhD, Head of mRNA Platform Design Data Science, Sanofi
John Quackenbush, PhD, Henry Pickering Walcott Professor of Computational Biology & Biostatistics, Harvard TH Chan School of Public Health
Daniel Reker, PhD, Assistant Professor of Biomedical Engineering, Duke University
10:00AM - 10:15PM
Time-To-Market: An Obvious Yet Perpetual Challenge
Speakers:
Clare Beddoes, PhD, Head of Drug Delivery, Cambridge Design Partnership
Showing Events in 1 Track from 10:15am to 11:05am
PODD Grand Opening Networking Break & Partnering
10:15AM - 11:05AM
PODD Grand Opening Networking Break & Partnering
Graciously hosted by:
Showing Events in 1 Track from 11:05am to 11:30am
Sustainability Keynote
11:05AM - 11:30AM
Sustainability Keynote - Laying a Path for a More Sustainable Future in the Device R&D Space
Speakers:
Marianne Ølholm, DVM, PhD, DMSc, Senior Vice President, Devices & Delivery Solutions, Novo Nordisk
Ann Daugherty, PhD, Senior Manager, Genentech
Showing Events in 1 Track from 11:30am to 12:30pm
Morning Second Session
11:30AM - 11:45AM
De-Risking Combination Product Development to Support Biocompatibility and Minimize Development Timelines
Speakers:
Yitian Xiao, Scientific Business Development Leader, BD Medical
11:45AM - 12:15PM
13th Annual Pharma Company Spotlights
Speakers:
Ester Caffarel-Salvador, PhD, Associate Director, Strategic Innovation, Rare Diseases, Chiesi USA
Annette Bak, PhD, MBA, Head of Advanced Drug Delivery, AstraZeneca
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
Jim MacKrell, PhD, Associate Vice President & Head of East Coast (US) Venture Science - Lilly New Ventures, Eli Lilly and Company
With:
12:15PM - 12:30PM
Lost in Translation: Interpreting Between Science, Design and Manufacturing of Platform Drug Delivery Devices
Speakers:
Tony Bedford, Commercial Director, Platform Management & Innovation, Phillips-Medisize
Showing Events in 1 Track from 12:30pm to 01:40pm
Luncheon & Partnering Meetings
12:30PM - 1:40PM
Luncheon & Partnering Meetings
Showing Events in 4 Tracks from 01:55pm to 03:55pm
Track 1A: Injectable Formulations & Polymers
Chaired by:
Srini Sridharan, PhD, Executive Director, Drug Delivery & Product Integration, Bristol-Myers Squibb
1:55PM - 2:10PM
Container Closure Integrity Phenomenology and Failure Mechanisms During Deep Cold Storage
Speakers:
Sukanya Murali, PhD, Technical Services Manager, Key Accounts, BD
2:10PM - 2:25PM
SynBiosys®: Long-Acting Injectable Microspheres & In Situ Forming Depots for Delivery of Small Molecules & Biologics
Speakers:
Rob Steendam, PhD, Chief Technology Officer, InnoCore Pharmaceuticals
2:25PM - 2:40PM
Apisolex™ Polymer: A New Enabling Tool for Insoluble Injectables – Simple Processing, High Drug Loading, and Lifecycle Management
Speakers:
Robert Lee, President, CDMO Division, Lubrizol Life Science
2:40PM - 2:55PM
A Novel Surfactant Dramatically Increasing the Stability and Concentration of Biologic Formulations
Speakers:
Bryan Mazlish, CEO, Surf Bio
2:55PM - 3:10PM
PharmaShell – New Possibilities for Long-Acting Injectable Formulations
Speakers:
David Westberg, CEO, Nanexa
3:10PM - 3:25PM
XeriJect™: Enabling Subcutaneous Delivery of High-Concentration Monoclonal Antibodies
Speakers:
Rick Fitch, PhD, Senior Director, Nonclinical Research & Development, Xeris Pharmaceuticals
3:25PM - 3:40PM
Scale-Up Challenges and Solutions for Long-Acting Injectables
Speakers:
Colin Spencer, Head of Technology Transfer, Project Manager, Oakwood Labs
3:40PM - 3:47PM
Pendant Functionalized Polymers: Boldly Going Where No PLGA Has Gone Before
Speakers:
C Eric Elmquist, PhD, COO of R&D, Pendant Biosciences
3:47PM - 3:55PM
SQore™ Enabled High Concentration mAb Formulations for Patient-Delivered Subcutaneous Delivery
Speakers:
Yuhong Zeng, PhD, Director of Formulation, Comera Life Sciences
Track 1B: Oral, Mucosal, Nasal and Other Non-Injectable Technologies
Chaired by:
Sarah Tao, PhD, Head of External Innovation, Biologics and Small Molecules Sanofi Partnering, Global Business Development and Licensing, Sanofi
1:55PM - 2:10PM
Nasal Routes Explored: Diving into Intranasal Delivery and Essential Aspects
Speakers:
Reenal Gandhi, Director, Business Development, Aptar Pharma
2:10PM - 2:25PM
Apinovex™ Polymer: A New Tool for Oral Solubility Enhancement, Improved Patient Experience and Lifecycle Management
Speakers:
Nick DiFranco, MEM, Global Market Manager, Oral Drug Delivery and Novel Excipients, Lubrizol Life Science
2:25PM - 2:40PM
Multiparticulates – A Versatile Tool For Patient-Centric Fixed Dose Combination Applications
Speakers:
Srinivasan Shanmugam, PhD, Executive Director, Pharmaceutical Sciences, Business Support & New Technologies, Adare Pharma Solutions
2:40PM - 2:55PM
Controlling Drug Release Rate and Location Through 3D Printed Dosage Forms
Speakers:
Timothy Tracy, PhD, Senior Advisor, Triastek
2:55PM - 3:10PM
Best Practices for Optimizing Route of Delivery for Improving Drug Development Outcomes
Speakers:
Ryan Doxey, Director, Technical Services, Kymanox
Stefanie Johns, PhD, Director, Regulatory Affairs, Kymanox
3:10PM - 3:25PM
BIONDD™ – Oral Delivery of Biologics – Effective Transitioning Injectables to a Capsule
Speakers:
Karsten Lindhardt, MSc, PhD, DBE, CEO and Founder, Biograil ApS
3:25PM - 3:40PM
SpraySol – A Solution for NCE’s with Low Bioavailability
Speakers:
Usha Pillai, PhD, PMP, PhD, PMP, Pharmacin
3:40PM - 3:47PM
Solving the Insoluble – A Eutectic Approach to Enhancing Oral Bioavailability
Speakers:
Niall Hodgins, Co-Founder & CEO, SeraNovo
3:47PM - 3:55PM
Can Spraying be Precise? Introducing SPRACISE® – a Novel Platform for Localized Deep Nasal Delivery.
Speakers:
Oren Berkowitz, PhD, Clinical Lead, Clexio
Track 1C: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Cameron Lee, PhD, Associate Director, Novartis Institutes for BioMedical Research
1:55PM - 2:10PM
New Perspectives on Nanoparticle Platforms for Navigating Genetic Nanomedicine Through Regulatory Pathways
Speakers:
Anthony Duong, PhD, Principle Research Scientist, Battelle
2:10PM - 2:25PM
A Novel Prefilled Drug Delivery Platform: Expanding Access and Distribution
Speakers:
Bo Kowalczyk, MBA, Chief Commercial Officer, ApiJect
2:25PM - 2:40PM
Designing for Human Nature: What Makes a Truly Engaging Drug Delivery Solution?
Speakers:
Dan Lock, Design Insight & Strategy Lead, TTP
2:40PM - 2:55PM
Double Development, Double Speed
Speakers:
Matthew Fordham, Deputy Head of Drug Delivery & Head of Client Management, Cambridge Design Partnership
2:55PM - 3:10PM
Scalable, Translatable, Dependable – Renishaw’s Delivery Platform for Drugs & Biologics
Speakers:
Stuart Campbell, Clinical Sales & Business Development Manager, Renishaw
3:10PM - 3:25PM
Revolutionary Gas-Powered Auto-injector Platform for All Drug Viscosities and Volumes
Speakers:
Matt McCawley, CTO, Altaviz, Picocyl
3:25PM - 3:40PM
The LTS Sorrel Platform – Solving Dilemmas in the Fill/Finish Process
Speakers:
Greg Moakes, PhD, MBA, Executive Vice President, Business Development, Sorrel Platform, LTS Lohmann Therapie-Systeme AG, LTS Device Technologies
3:40PM - 3:47PM
Next Generation Smart Needle-Free Drug Delivery Platform Targeting Frequent Injections in Remote Healthcare Setting
Speakers:
Alina Su, PhD, Founder & CEO, NovaXS
3:47PM - 3:55PM
A Rugged, Reliable, Portable, Safe and Simple Auto-Injector
Speakers:
Conor Cullinane, PhD, President & CEO, Pirouette Medical
Track 1D: Cell & Gene Delivery
Chaired by:
Ashoka Madduri, PhD, MBA, Head of Scientific Strategy & Competitive Intelligence, mRNA Center of Excellence, Sanofi
1:55PM - 2:10PM
Biodegradable Lipid Nanoparticles for Gene Therapy and Vaccines with Room Temperature Stability
Speakers:
Sakura Taneichi, Research Scientist, NOF Corporation
2:10PM - 2:25PM
Advances in Nanotechnologies for Delivery of Biologics and Small Molecules
Speakers:
Shaukat Ali, PhD, Senior Director, Scientific Affairs & Technical Marketing, Ascendia Pharmaceuticals
2:25PM - 2:40PM
SORT LNP-formulated mRNA for the Treatment of Primary Ciliary Dyskinesia
Speakers:
Brandon Wustman, PhD, Senior Vice President, Research, ReCode Therapeutics
2:40PM - 2:55PM
Pioneering Programmable Medicines
Speakers:
Stuart Milstein, PhD, Chief Platform Officer, Senda Biosciences
2:55PM - 3:10PM
Establishing a Robust Process Control Strategy for NA-LNPs
Speakers:
Antonio Costa, PhD, CEO, DIANT Pharma
3:10PM - 3:25PM
Choosing the Right Microfluidic Mixing Platform: How Critical is This First Step Towards the Clinic?
Speakers:
Nicholas Boylan, PhD, Director, Nucleic Acid Delivery, Phosphorex
3:25PM - 3:40PM
Ushering in the New Era of Genetic Medicine with the Fusogenix Proteo-Lipid Vehicle Delivery Platform
3:40PM - 3:47PM
Dose-Adjustable Gene Therapy Platform Technology – Prometheus
Speakers:
Alex Goraltchouk, MBA, COO, Remedium Bio
3:52PM - 3:55PM
Immuno-LNP Delivers Diverse Therapeutic Payloads Across the BBB
Speakers:
Joe Harford, PhD, President & CEO, SynerGene Therapeutics
Showing Events in 1 Track from 03:55pm to 04:10pm
Break
3:55PM - 4:10PM
15-Minute Ice-Cream Break (3rd Floor)
Graciously Hosted by:
Showing Events in 4 Tracks from 04:15pm to 06:30pm
Track 1B: Self-Injection Devices, Syringes, Primary Container & Packaging Solutions
Chaired by:
Sherri Biondi, PhD, Senior Director and Head of Device Development, AstraZeneca
4:15PM - 4:30PM
A Novel Method to Optimizing Drug Delivery for Parenteral Products Involving New Therapies and Unmet Needs
Speakers:
Asmita Khanolkar, Senior Director, SMC LTD
4:30PM - 4:45PM
Molly Connected Cap Shapes Pharma’s Digital Health Path with Innovation Partnerships
Speakers:
Nagisa Kobashi, Product Manager for Global Emerging Technology & Digital Health, SHL Medical
4:45PM - 5:00PM
De-Risking Combination Product Programs Through a Collaborations’ Integrated Device Approach From Primary Package to Final Assembly
Speakers:
Josh Gordon, Product Manager, Auto-Injectors, Stevanato Group
5:00PM - 5:15PM
Addressing Unsolved Autoinjector Needs is Key to Enable Administration of High-Dose Biologics
Speakers:
Gaurtam Shetty, PhD, Founder & CEO, Congruence Medical Solutions
5:15PM - 5:30PM
Syringe System Innovation Driving Evolution Of Dual-Chamber Prefilled Syringe System Design, Development & Manufacturing
Speakers:
Laxman Halleppanavar, Director - Commercial Engineering Project Management, Credence Medsystems
5:30PM - 5:45PM
Technical & Human Factors Considerations for High Viscosity/High Volume Injection
Speakers:
Michael Roe, PE, Senior Director, Development & Industrialization, Kaléo
5:45PM - 6:00PM
Maximizing the Value Your Material Supplier Can Bring to Your Drug Delivery Device Design for Precision Friction Performance
Speakers:
Don DeMello, Principal Application Development Engineer - Medical, Celanese
6:00PM - 6:15PM
Ypsomed’s Approach to the Growing Market for Injection Device Solutions
Speakers:
Philipp Richard, MBA, Account & Business Development Manager, Ypsomed
Track 2B: Injectable & Non-Injectable Formulation Technologies
Chaired by:
Sudhakar Garad, PhD, Global Head of Chemical and Pharmaceutical Profiling, NIBR
4:15PM - 4:30PM
Polymeric Drug Delivery Technology for Sustained Release of Small and Large Molecules
Speakers:
Keith Henry, MBA, New Business Development Leader, Celanese
4:30PM - 4:45PM
From Micro to Nano: Block Copolymers Enable Nanoparticle Drug Products for the Treatment of New Therapeutic Modalities
Speakers:
Whitney Beysselance Moro, PhD, Director, Strategic & Technical Marketing, Evonik
4:45PM - 5:00PM
The Viscosity Reduction Platform: An Excipient Portfolio Enabling Reduction of Viscosity While Maintaining Protein Stability
Speakers:
Lydon Salins, PhD, Technical Application Manager, Biomolecule/Liquid Formulation, Millipore Sigma
5:00PM - 5:15PM
Overcoming Challenges with Formulation of Nucleophilic APIs in the Development of Long-Acting Therapies
Speakers:
George Mihov, PhD, Principal Scientist - Drug Delivery Solutions, DSM Biomedical
5:15PM - 5:30PM
PURASORB® Lactide-Glycolide Bioresorbable Copolymers for Creating Effective Long-Acting Injectables
Speakers:
Julien Bérard, MBA, Global Director, Business Development Biomaterials, Corbion
5:30PM - 5:45PM
BEPO Technology: Addressing Patient Needs Through Best-In-Class Long-Acting Injectables
Speakers:
Christophe Roberge, PhD, Partnering Director, Senior Expert Science & Technology, MedinCell
5:45PM - 6:00PM
Benefits of Diffusion-Based Implantable Drug Delivery Technology for Long-Term Delivery Windows (6-12 mo.) Mediated via Porous Media
Speakers:
Alex Hill, Senior Research Scientist, Mott Corporation
6:00PM - 6:07PM
Robust Delivery of Biologics with Novel DELOS Nanovesicles
Speakers:
Alba Córdoba, PhD, Tech Transfer & Business Development Director, Nanomol Technologies
6:07PM - 6:15PM
Revolutionizing Antiviral Treatments – Orally Available Nanomedicines that Can Also Deliver Difficult APIs and Improve Their PK
Speakers:
Anil Diwan, PhD, President & Exectuive Chairman, Nanoviricides
Track 3B: Connected Devices, Wearables & Other Novel Devices
Chaired by:
Ulrich Brüggemann, Lead Advanced Drug Delivery Technical Development, Takeda Pharmaceuticals
4:15PM - 4:30PM
Revolutionizing Injectable Therapies: Overcoming Key Challenges in Drug Delivery with a Needle-Free and Connected Solution
Speakers:
Veena Rao, PhD, President & Chief Business Officer, Portal Instruments
4:30PM - 4:45PM
Advancements in Micro Molding for Drug Delivery – What is Now Possible
Speakers:
Brent Hahn, MBA, VP, Business Development & Strategy, Isometric Micro Molding
4:45PM - 5:00PM
How Pharma Can Avoid Creating Dysfunctional Connected Device Development Programs & Organizations
Speakers:
Jim McGough, Co-Founder & Director, EdgeOne Medical
5:00PM - 5:15PM
Halozyme’s ENHANZE Drug Delivery Technology Enables Rapid High Volume Subcutaneous Drug Delivery Expanding Autoinjector
Speakers:
Michael LaBarre, PhD, Chief Technical Officer, Halozyme
5:15PM - 5:30PM
What’s Beyond 10mL? Unique Learnings in Large Volume Subcutaneous Infusion
Speakers:
Josh Bennett, General Manager of Novel Therapies, Koru Medical
5:30PM - 5:45PM
Potential Financial Cost Implications When Developing a Connected Drug Delivery Device, Versus a Non-Connected Product
Speakers:
Chris Hurlstone, Technical Director, Team Consulting
5:45PM - 6:00PM
How to Better Deal With the Challenges of Mixing & Delivering Highly Viscous Drugs
Speakers:
Claire Authesserre, PhD, Project Manager, Eveon
6:00PM - 6:15PM
Accelerating Development of User-Driven Connected Devices & Combination Products
Speakers:
Mark Tunkel, Global Category Director, Services, Nemera
6:15PM - 6:22PM
Reimagining the Potential of Intradermal Delivery with a Novel Injection Platform
Speakers:
Nicky Bertollo, PhD, Co-Founder & CTO, Pharma Latch
6:22PM - 6:30PM
Revolutionizing Drug Delivery to Challenging Brain Regions for a Diverse Range of Therapeutics & Localized Brain Conditions
Speakers:
Paul Schultz, SVP, Business Development, Bionaut Labs
Track 4B: Cell, Gene & Other Biologics Delivery
Chaired by:
Andrew Kroetsch, PhD, Associate Director, Takeda Pharmaceuticals
4:15PM - 4:30PM
The Potential of Eliminating Cold Chain Storage for Vaccine Distribution & Delivery
Speakers:
Mike Ratigan, Commercial Head, Advanced Pulmonary Delivery, Kindeva Drug Delivery
4:30PM - 4:45PM
Redefining Non-Viral Delivery for Novel Genomic Medicines with Hopewell’s Tissue-Targeted Lipid Nanoparticle (ttLNP) Platformn
Speakers:
Kate Zhang, PhD, Chief Scientific Officer, Hopewell Therapeutics
4:45PM - 5:00PM
Modulating Neutrophil Activity in Disease Using Targeted mRNA and Small Molecule Delivery
5:00PM - 5:15PM
BactPac™: A Bacteria-based Drug Delivery Platform to Enable the Next Generation of Nucleic Acid and Gene Therapies
Speakers:
Ashley Williams, PhD, Director of Research & Development, SiVec Biotechnologies
5:15PM - 5:30PM
Sustained Release Biologic Implants for the Treatment of Retinal Disease
Speakers:
Patrick Ruane, PhD, Chief Operating Officer, Re-Vana Therapeutics
5:30PM - 5:45PM
Turning Implantable Devices into Therapeutic Treatments: Ushering in the Next Evolution in Targeted Therapies
Speakers:
Luis Alvarez, PhD, Founder & CEO, Theradaptive
Showing Events in 1 Track from 06:30pm to 07:35pm
Networking
6:30PM - 7:30PM
PODD Networking Reception & Partnering Meetings
Graciously Hosted by:
7:30PM - 7:35PM
Day One Concludes
Previous
Day 1 October 16, 2023
Monday, October 16, 2023

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.